Brief: Alx Oncology Announces First Patient Dosed In The I-SPY-P1 Trial In Breast Cancer
13/03/2023 11:41
March 13 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY AND QUANTUM LEAP HEALTHCARE COLLABORATIVE™
ANNOUNCE
FIRST PATIENT DOSED IN THE I-SPY-P1 TRIAL IN BREAST CANCER
Source text for Eikon: ID:nGNX6TyvnP
Further company coverage: ALXO.O
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing